Is there a set date for onglyza's generic launch?

There isn’t a fixed “set date” for a generic version of Onglyza (saxagliptin) to launch. Generic availability depends on patent expirations and any related legal settlements or exclusivities. In the U.S. the key patent and regulatory protections must expire or be overcome before a generic can hit the market.

What you can do to verify current status:
- Check the FDA’s Orange Book (Patents and Exclusivity for saxagliptin/Onglyza) to see which patents are listed and their expiration dates.
- Look for any recent updates from the FDA or from major pharma news about settlements or generic filings for saxagliptin.
- If you’re outside the U.S., check the local regulatory agency and local patent status, as timelines can differ by country.

If you’d like, I can look up the latest status for you (patent/exclusivity details and any announced generic filings) if you want me to search online.